Infographic: Long-Term Data on Switching to Biosimilar Infliximab

November 5, 2017
The Center for Biosimilars Staff

Two recent studies have provided long-term data on the safety and efficacy of switching patients from Remicade to its biosimilars.

Two recent studies have provided long-term data on the safety and efficacy of switching patients from Remicade to its biosimilars.